Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network

This publication has 21 references indexed in Scilit:

• The clinical importance of free prostate‐specific antigen (PSA)
  Current Opinion in Urology, 1998
• Development of a decision-making tool to predict risk of prostate cancer: The cancer of the prostate risk index (CAPRI) test
  Urology, 1997
• Free and complexed prostate-specific antigen serum ratios to predict probability of primary prostate cancer and benign prostatic hyperplasia
  Urology, 1996
• Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: Influence of total psa, prostate volume, and age
  Urology, 1996
• Screening for Prostate Cancer with Prostate-Specific Antigen — An Examination of the Evidence
  New England Journal of Medicine, 1995
• Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening
  Published by American Medical Association (AMA) ,1995
• Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges
  JAMA, 1993
• Bayesian Interpolation
  Neural Computation, 1992
• Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease
  JAMA, 1992
• Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer
  New England Journal of Medicine, 1991